IRIS
LEONCINI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.671
AS - Asia 1.379
NA - Nord America 1.338
Continente sconosciuto - Info sul continente non disponibili 239
SA - Sud America 131
AF - Africa 20
OC - Oceania 5
Totale 16.783
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.422
US - Stati Uniti d'America 1.262
SG - Singapore 589
CN - Cina 354
VN - Vietnam 183
BD - Bangladesh 141
FR - Francia 109
BR - Brasile 81
HK - Hong Kong 45
FI - Finlandia 29
CA - Canada 27
DE - Germania 27
AR - Argentina 22
CH - Svizzera 22
IQ - Iraq 15
GB - Regno Unito 13
JP - Giappone 13
MX - Messico 13
NL - Olanda 11
CO - Colombia 8
IN - India 8
VE - Venezuela 7
NI - Nicaragua 6
ZA - Sudafrica 6
CR - Costa Rica 5
EC - Ecuador 5
HN - Honduras 5
ID - Indonesia 5
IE - Irlanda 5
JM - Giamaica 5
PH - Filippine 5
UA - Ucraina 5
AU - Australia 4
DZ - Algeria 4
PK - Pakistan 4
PL - Polonia 4
RU - Federazione Russa 4
AT - Austria 3
CL - Cile 3
EG - Egitto 3
ES - Italia 3
GT - Guatemala 3
MA - Marocco 3
PY - Paraguay 3
DO - Repubblica Dominicana 2
JO - Giordania 2
KY - Cayman, isole 2
LT - Lituania 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
MF - Saint Martin 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PF - Polinesia Francese 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 16.545
Salva come PNG Salva come JPEG
Città #
Genova 7.961
Genoa 3.354
Rapallo 1.087
Vado Ligure 853
San Jose 333
Singapore 308
Lauterbourg 105
Ashburn 92
New York 67
Ho Chi Minh City 56
Beijing 48
Hanoi 43
Hong Kong 43
Santa Clara 38
Council Bluffs 33
Helsinki 29
Los Angeles 23
Zurich 21
Bordighera 20
Frankfurt am Main 19
Rome 16
Atlanta 13
Phoenix 12
Tokyo 12
São Paulo 11
Buffalo 10
Chicago 10
Mexico City 9
Orem 9
Dallas 8
Las Vegas 8
Milan 8
Da Nang 7
Naples 7
Philadelphia 7
Amsterdam 6
Bari 6
Boardman 6
Florence 6
Managua 6
Palermo 6
San Antonio 6
Tampa 6
The Bronx 6
Baghdad 5
Bologna 5
Brooklyn 5
Charlotte 5
City of London 5
Des Moines 5
Dublin 5
Miami 5
Tianjin 5
Toronto 5
Turin 5
Buenos Aires 4
Houston 4
Kingston 4
Memphis 4
Nuremberg 4
San José 4
Sydney 4
Topeka 4
Birmingham 3
Biên Hòa 3
Bogotá 3
Cazzago San Martino 3
Charleston 3
Cincinnati 3
Duhok 3
East Brunswick 3
Fort Worth 3
Haiphong 3
Hempstead 3
Oswego 3
San Francisco 3
Secaucus 3
Shanghai 3
St Louis 3
Tegucigalpa 3
Verona 3
Akron 2
Alameda 2
Alexandria 2
Asheboro 2
Baltimore 2
Barquisimeto 2
Boston 2
Brampton 2
Brasília 2
Bratislava 2
Brescia 2
Bắc Ninh 2
Cairo 2
Cape Town 2
Caracas 2
Chaguanas 2
Chennai 2
Chula Vista 2
Colorado Springs 2
Totale 14.913
Salva come PNG Salva come JPEG
Nome #
Chronic intake of micrograms of abscisic acid improves glycemia and lipidemia in a human study and in high-glucose fed mice 382
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
Left ventricular dilatation and subclinical renal damage in primary hypertension 265
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 220
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 205
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 203
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 202
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 192
C-reactive protein and target organ damage in untreated patients with primary hypertension. 186
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 184
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 182
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 181
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 180
Cardiovascular and renal effects of hyperuricaemia and gout. 179
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 179
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 177
Renal and cardiac abnormalities in primary hypertension 174
Blood pressure variability and multiple organ damage in primary hypertension 172
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 170
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 170
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 165
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 165
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 159
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 158
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 158
Creatinine clearance and early signs of target organ damage in primary hypertension 157
Use of nifedipine in the treatment of hypertension. 156
Sub-clinical organ damage in hypertension and obesity 156
Elderly Woman With Abnormal ECG 156
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 155
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 154
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 154
Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency 153
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 153
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 152
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 151
Hyperuricemia and renal risk 151
Mild renal dysfunction and renal vascular resistance in primary hypertension 150
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 148
7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 146
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma? 145
Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients 143
Overall health assessment: a renal perspective. 143
Chronic kidney disease and albuminuria in arterial hypertension. 143
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 142
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 142
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 141
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 139
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 139
A very low vitamin D threshold, within the range of severe deficiency, identifies an increased risk of non-classical vitamin D-related outcomes in medical inpatients: a role for parathyroid hormone? 139
Serum uric acid as a marker of target organ damage in primary hypertension 138
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 138
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 137
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 137
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 137
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 136
Dyspnoea after home improvement work 136
Antihypertensive therapy in hypertensive patients with metabolic syndrome. 134
RAAS Inhibition and Renal Protection 134
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits 133
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOVASCULAR AND RENAL DISEASE AN OLD CONTROVERSY REVIVED. 132
Blood pressure load, vascular permeability and target organ damage in primary hypertension 131
Global risk stratification in primary hypertension: the role of the kidney 130
Metabolic syndrome and microalbuminuria predict renal outcome in non-diabetic patients with primary hypertension: the MAGIC study. 130
Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC Study 128
Target organ damage and metabolic syndrome in non diabetic hypertensive patients 128
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 126
Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study. 126
Creatinine clearance and signs of end-organ damage in primary hypertension. 125
Vascular permeability, blood pressure, and organ damage in primary hypertension 125
Left ventricular geometry and function in patients with essential hypertension and microalbuminuria 124
Pulse pressure and subclinical cardiovascular damage in primary hypertension 124
Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised? 124
Coronary flow reserve is impaired in uncomplicated hypertensive patients with renal dysfunction 123
Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. 123
Microalbuminuria blood pressure load, and systemic vascular permeability in primary hypertension 120
Blood pressure phenotype: an evolving picture 120
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 120
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. 119
Cardionephrology, an emerging discipline: Highlights of the sixth Genoa meeting on hypertension, diabetes and renal diseaseTherapy 117
Mild hyperuricemia and sub-clinical renal damage in primary hypertension 116
Chronic kidney disease in the hypertensive patient: an overview of the I-DEMAND study. 115
Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. 115
Microalbuminuria in primary hypertension 114
Serum uric acid and target organ damage in primary hypertension. 113
Serum IGF-I concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D. 112
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. 110
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study 106
Mild renal dysfunction and subclinical organ damage in primary hypertension 106
Fructose and uric acid: Major mediators of cardiovascular disease risk starting at pediatric age 106
Long-term blood pressure variability, incidence of hypertension and changes in renal function in type 2 diabetes 106
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 105
Looking at the kidney to predict global outcome in the elderly 104
MICROALBUMINURIA PREDICTS CHRONIC RENAL INSUFFICIENCY IN NON DIABETIC HYPERTENSIVE PATIENTS: THE MAGIC STUDY LONG TERM FOLLOW UP JOURNAL OF HYPERTENSION 103
Two-Day ABPM-Derived Indices and Mortality in Hemodialysis Patients 101
Totale 14.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.189
article - articoli 54.314
book - libri 0
conference - conferenze 721
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 154
Totale 110.378
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.399 49 82 77 169 54 120 105 324 45 146 58 170
2022/20231.346 128 81 12 146 195 233 41 93 215 53 106 43
2023/2024705 42 83 19 78 71 124 33 43 43 8 55 106
2024/20252.259 55 165 68 143 292 220 232 361 110 118 251 244
2025/20263.765 439 117 252 338 409 341 602 159 217 320 208 363
2026/2027556 556 0 0 0 0 0 0 0 0 0 0 0
Totale 16.783